LIGAND PHARMACEUTICALS INCORPORATED Effective Income Tax Rate Reconciliation Cross Border Other Amount
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Effective Income Tax Rate Reconciliation Cross Border Other Amount of $6.06 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation cross border other amount for fiscal 2025 was $6.06M, a 7.33% increase from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation cross border other amount for fiscal 2024 was $5.65M, a 1079.33% increase from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation cross border other amount for fiscal 2023 was $479.00K.
| Period end | Effective Income Tax Rate Reconciliation Cross Border Other Amount 12 month |
|---|---|
| 2025-12-31 | $6.06M 10-K · filed 2026-02-27 |
| 2024-12-31 | $5.65M 10-K · filed 2026-02-27 |
| 2023-12-31 | $479.00K 10-K · filed 2026-02-27 |